Savant Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Buy
5,020
+5
+0.1% +$518 ﹤0.01% 1210
2026
Q1
$485K Sell
5,015
-147
-3% -$15.1K ﹤0.01% 926
2025
Q4
$548K Buy
5,162
+3,009
+140% +$349K ﹤0.01% 800
2025
Q3
$274K Buy
2,153
+8
+0.4% +$952 ﹤0.01% 1081
2025
Q2
$263K Buy
+2,145
New +$245K ﹤0.01% 1008
2025
Q1
Sell
-2,279
Closed -$210K 1190
2024
Q4
$210K Sell
2,279
-114
-5% -$11.2K ﹤0.01% 1296
2024
Q3
$231K Sell
2,393
-671
-22% -$60.3K ﹤0.01% 1216
2024
Q2
$263K Buy
+3,064
New +$257K ﹤0.01% 1030

Other funds holding EHC

Savant Capital's EHC Position: Q2 2026 in Review

Savant Capital increased its Encompass Health (EHC) stake by 0.1% in Q2 2026, buying an estimated $518 and bringing the position to 5,020 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.

Savant Capital first reported a position in EHC in Q2 2024 and has held it in 8 quarters since. The position peaked at $548K in Q4 2025. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Savant Capital held 5,020 shares of Encompass Health worth $508K as of Q2 2026.
  • Savant Capital bought 5 Encompass Health shares in Q2 2026, an estimated $518.
  • Encompass Health made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #1210 holding.
  • Savant Capital first reported a position in Encompass Health in Q2 2024 and has held it in 8 quarters since.
  • Savant Capital's Encompass Health position peaked at $548K in Q4 2025.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.